Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
NASDAQ:DXCM
Price:
128.37 USD
1.36%
Market Closed
Updated:
May 5, 2024
Dexcom Inc
Cash from Investing Activities
|
Dexcom Inc
Cash from Investing Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Dexcom Inc
NASDAQ:DXCM
|
Cash from Investing Activities
-$245.7m
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Investing Activities
-$658m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
4%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Investing Activities
-$2.6B
|
CAGR 3-Years
-114%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-17%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Investing Activities
-$1.2B
|
CAGR 3-Years
36%
|
CAGR 5-Years
12%
|
CAGR 10-Years
6%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-3%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Investing Activities
-$1.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
See Also
What is Dexcom Inc's Cash from Investing Activities?
Cash from Investing Activities
-245.7m
USD
-245.7m
USD
Based on the financial report for Mar 31, 2024, Dexcom Inc's Cash from Investing Activities amounts to -245.7m USD.
What is Dexcom Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
42%
42%
Over the last year, the Cash from Investing Activities growth was 17%. The average annual Cash from Investing Activities growth rates for Dexcom Inc have been 42% over the past three years .
You don't have any saved screeners yet
